| 2025-01-28 19-43-49 | Reducing Alkaline Phosphatase (ALP) function causes accumulation of Pyrophosphate (PPi), Pyridoxal 5'-Phosphate (PLP, Vitamin B6), and Phosphoethanolamine (PEA) |
| 2025-01-28 19-42-55 | Reduced plasma Alkaline Phosphatase (ALP) and elevated plasma Pyridoxal 5'-Phosphate (PLP, Vitamin B6), Pyrophosphate (PPi), and/or Phosphoethanolamine (PEA) can help diagnose Hypophosphatasia |
| 2025-01-28 19-07-37 | Elevated serum Pyridoxal 5'-Phosphate (PLP, Vitamin B6) can help diagnose Hypophosphatasia |
| 2025-01-22 17-59-49 | Niacin (VItamin B3) and Pyridoxal 5'-Phosphate (PLP, Vitamin B6) accelerate muscle regeneration |
| 2025-01-22 13-09-07 | Hypophosphatasia patients with ALPL variants can be identified based on Alkaline Phosphatase (ALP) < 25 IU/L and Pyridoxal 5'-Phosphate (PLP, Vitamin B6) > 180 nmol/L |
| 2025-01-22 12-26-56 | Increased levels of Pyridoxal 5'-Phosphate (PLP, Vitamin B6) and Phosphoethanolamine (PEA) are associated with increased Bone Mineral Density (BMD) in the lumbar spine of patients with Hypophosphatasia |